What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
Ritsuro Suzuki mainly focuses on Internal medicine, Lymphoma, Immunology, Pathology and Transplantation.
His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine.
His Oncology research incorporates elements of Disease and Retrospective cohort study.
In Lymphoma, Ritsuro Suzuki works on issues like Immunophenotyping, which are connected to CD5.
His study in Pathology is interdisciplinary in nature, drawing from both Null cell and Immunodeficiency.
The Transplantation study combines topics in areas such as Complication and Bone marrow.
His most cited work include:
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. (995 citations)
- RET, ROS1 and ALK fusions in lung cancer. (941 citations)
- A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details (525 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Transplantation, Lymphoma, Oncology and Hematopoietic stem cell transplantation.
Ritsuro Suzuki has included themes like Gastroenterology, Surgery and Immunology in his Internal medicine study.
His Transplantation research integrates issues from Incidence, Regimen, Retrospective cohort study, Stem cell and Leukemia.
His Lymphoma research includes elements of Cancer research and Immunophenotyping.
His Oncology study incorporates themes from Myeloid leukemia and Refractory.
His studies in Hematopoietic stem cell transplantation integrate themes in fields like Aplastic anemia, Acute lymphocytic leukemia, Cord blood and Graft-versus-host disease.
He most often published in these fields:
- Internal medicine (66.43%)
- Transplantation (40.90%)
- Lymphoma (33.57%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (66.43%)
- Oncology (31.21%)
- Transplantation (40.90%)
In recent papers he was focusing on the following fields of study:
Ritsuro Suzuki spends much of his time researching Internal medicine, Oncology, Transplantation, Lymphoma and Hematopoietic stem cell transplantation.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.
His work on Autologous stem-cell transplantation and Performance status as part of general Oncology research is frequently linked to In patient, bridging the gap between disciplines.
His Transplantation research is multidisciplinary, incorporating elements of Hematopoietic cell, Cord blood, Stem cell and Leukemia, Acute leukemia.
His Lymphoma study integrates concerns from other disciplines, such as Peripheral T-cell lymphoma, Young adult, Incidence and Hazard ratio.
Ritsuro Suzuki interconnects Cancer research, Mycosis fungoides and Post-transplant lymphoproliferative disorder in the investigation of issues within Hematopoietic stem cell transplantation.
Between 2018 and 2021, his most popular works were:
- Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. (20 citations)
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. (10 citations)
- ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients. (10 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Ritsuro Suzuki focuses on Internal medicine, Transplantation, Oncology, Lymphoma and Hematology.
His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology.
His Transplantation research is multidisciplinary, relying on both Leukemia, Acute leukemia and Confidence interval.
His Oncology research is multidisciplinary, incorporating perspectives in Imatinib, Refractory and Pooled analysis.
His work deals with themes such as Virology and Hazard ratio, which intersect with Lymphoma.
Ritsuro Suzuki focuses mostly in the field of Hematology, narrowing it down to matters related to Peripheral T-cell lymphoma and, in some cases, Hematologic Neoplasms, Cancer research, Angioimmunoblastic T-cell lymphoma and Not Otherwise Specified.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
